Status:
UNKNOWN
Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia
Lead Sponsor:
Assiut University
Conditions:
Gestational Trophoblastic Disease
Eligibility:
FEMALE
18-50 years
Phase:
PHASE2
PHASE3
Brief Summary
Gestational trophoblastic neoplasia (GTN) are malignant lesions that arise from abnormal proliferation of placental trophoblast. The pathologic conditions that make up this entity include invasive par...
Detailed Description
When reporting GTN data, it is useful to use both the FIGO anatomic staging system and prognostic scoring system . A FIGO score of 6 or less indicates low-risk GTN whereas a score of 7 or more identif...
Eligibility Criteria
Inclusion
- Age: 18-50
- BW: 50-100 kg
- willing and consenting to be enrolled in the study
- Absence of active vaginal bleeding which requires surgical intervention • - WHO score \<6
Exclusion
- Renal and liver dysfunction or blood dyscariasis
- high risk persistent gestational trophoblastic disease.
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2019
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT03280979
Start Date
October 1 2017
End Date
October 1 2019
Last Update
September 13 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.